ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01130142
Recruitment Status : Completed
First Posted : May 25, 2010
Last Update Posted : March 6, 2017
Sponsor:
Information provided by (Responsible Party):
Infinity Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2012
  Actual Study Completion Date : May 2012
  Certification/Extension First Submitted : June 13, 2013